Nanshan Elderly Cohort Study
NECS
1 other identifier
observational
20,000
1 country
2
Brief Summary
Objective: The Nanshan Elderly Cohort Study (NECS) aims to investigate the nutritional, as well as other environmental and genetic factors of chronic diseases, such as cardio-metabolic diseases. Study design: NECS is a community-based prospective cohort study. Participants: About 10000-20000 apparently healthy residents, living in Nanshan, Shenzhen (South China) for \>5 years, aged ≥ 65 years, will be recruited between 2018 and 2019. Visits and Data Collection: Participants will be followed up approximately every 3 years by invited to the Community Healthcare Service Centre. At each survey, face-to-face interviews, anthropometric measurements, ultrasonography examination, electrocardiogram test and specimen collection will be conducted. Key variables:
- 1.Face-to-face interviews: Structured questionnaires will be used to collect the participants' socio-demographic characteristics, lifestyles, habitual dietary intake, physical activity, history of chronic diseases, use of supplements and medications, family history, psychological health and cognitive function.
- 2.Physical examinations: Anthropometric measurements, blood pressure tests, handgrip strength, and usual gait speed.
- 3.Ultrasonography examinations: Ultrasonography examination will be performed to determine carotid artery intima-media thickness and plaque, fatty liver.
- 4.Electrocardiogram test: Electrocardiogram test is to obtain information about the structure and function of the heart.
- 5.Specimen collections: Overnight fasting blood sample, early morning first-void urine sample and faeces samples will be collected and stored at -80°C till tests.
- 6.Laboratory tests:
- 7.Blood tests: Metabolic syndrome-related indices; nutritional indices; inflammatory markers; sexual hormones; genetic markers.
- 8.Urinary tests: Flavonoids and flavones, minerals, creatinine and renal function related markers.
- 9.Fecal test: Gut microbiota and related metabolites.
- 10.Morbidity and mortality: Relevant data will be also retrieved via local multiple Health information systems.
- 11.Others: Many other laboratory tests or instrument tests will be developed depended on needs and resources in future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2018
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2018
CompletedStudy Start
First participant enrolled
May 26, 2018
CompletedFirst Posted
Study publicly available on registry
June 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2028
June 26, 2018
June 1, 2018
10.6 years
May 22, 2018
June 23, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Diabetes mellitus
The investigators will also track for occurrence of diabetes mellitus by follow-up surveys and annual record linkage to the population-based disease or death registry collected by the Shenzhen Center for Disease Control and Prevention and Health Insurance Bureau. All cases will be verified by medical record reviews.
Up to 10 years
Cardiovascular diseases (occurrence of cardiovascular diseases)
The investigators will track for occurrence of cardiovascular diseases by follow-up surveys and annual record linkage to the population-based disease or death registry collected by the Shenzhen Center for Disease Control and Prevention, and Health Insurance Bureau. All cases will be verified by medical record reviews.
Up to 10 years
Stroke (occurrence of stroke)
The investigators will track for occurrence of stroke by follow-up surveys and annual record linkage to the population-based disease or death registry collected by the Shenzhen Center for Disease Control and Prevention, and Health Insurance Bureau. All cases will be verified by medical record reviews.
Up to 10 years
Cognitive disorder (occurrence of cognitive disorder)
The investigators will track for occurrence of cognitive disorder by follow-up surveys and annual record linkage to the population-based disease or death registry collected by the Shenzhen Center for Disease Control and Prevention, and Health Insurance Bureau. All cases will be verified by medical record reviews.
Up to 10 years
Secondary Outcomes (4)
Metabolic syndrome
Up to 10 years
Change lipid profile
Up to 10 years
Handgrip strength
Up to 10 years
Usual gait speed
Up to 10 years
Eligibility Criteria
The participants who meet the inclusion and exclusion criteria will be recruited from all communities of Nanshan, Shenzhen by face-to-face communication.
You may qualify if:
- Age: ≥ 65 years;
- Living in Nanshan, Shenzhen for at least 5 years;
- Chinese.
You may not qualify if:
- Had a history of hospital-confirmed diabetes, failure(s) of heart, liver, or kidney, cancer, CVD events;
- On special diet due to a disease or weight control;
- Mental and physical disability;
- Likely to move to other city within 5 years;
- Did not want to attend any one item of the survey or sample collection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Department of Non-communicable Disease Prevention and Control, Shenzhen Nanshan Center for Chronic Disease Control
Shenzhen, Guangdong, 518054, China
Department of Medical Statistics & Epidemiology, School of Public Health, Sun Yat-sen University
Guangzhou, 510080, China
Biospecimen
Overnight fasting blood sample, early morning first-void urine sample and faeces samples will be collected at baseline and follow-up。
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yuming Chen
Sun Yat-sen University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 22, 2018
First Posted
June 26, 2018
Study Start
May 26, 2018
Primary Completion (Estimated)
December 30, 2028
Study Completion (Estimated)
December 30, 2028
Last Updated
June 26, 2018
Record last verified: 2018-06
Data Sharing
- IPD Sharing
- Will not share